James Carroll is an internationally recognized authority on Photobiomodulation (PBM) / Low Level Laser Therapy (LLLT) who collaborates with many universities and research centers on PBM, including Harvard Medical School and School of Public Health, MIT, Massachusetts General Hospital, and Leiden University Medical Centre (in Amsterdam). James has presented at a multitude of healthcare meetings literally around the world including both the United Nations Global Health Impact Forum and US Congress on the science and value that PBM has in healthcare. James has been described by Professor Mike Hamblin at Harvard Medical School as “The world’s leading ambassador for Low Level Laser Therapy”.
James is a Fellow of The Royal Society of Medicine and has served on the Board of Directors for both World Association for Laser Therapy (WALT) and North American Association for Light Therapy (NAALT). He is and expert editorial reviewer for Public Library of Science (PLoS ONE), Photomedicine and Laser Surgery, Photomedicine and Photochemistry and the Journal of Photochemistry and Photobiology Biology - Annals of Biomedical Engineering. James is one of the most recognized authorities in the world on PBM’s low level light therapies mechanisms of action, dose, dose rate effects and the measurement and reporting of parameters.
He is the Biomedical Optics Society Conference Chairman and founded THOR Photomedicine Ltd.in June of 1998 and has been the Chief Executive Officer since its inception.
Click Here to view James Carroll’s Congressional Briefing to the United States Congress.